These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 26142775)
1. A smart polymeric platform for multistage nucleus-targeted anticancer drug delivery. Zhong J; Li L; Zhu X; Guan S; Yang Q; Zhou Z; Zhang Z; Huang Y Biomaterials; 2015 Oct; 65():43-55. PubMed ID: 26142775 [TBL] [Abstract][Full Text] [Related]
2. Enhanced nuclear delivery of H1-S6A, F8A peptide by NrTP6-modified polymeric platform. Xie D; Wang F; Xiang Y; Huang Y Int J Pharm; 2020 Apr; 580():119224. PubMed ID: 32173501 [TBL] [Abstract][Full Text] [Related]
3. An in vitro investigation of a detachable fork-like structure as efficient nuclear-targeted sub-unit in A2780 cell cultures. Guan S; Li L; Zhu X; Yang Y; Zhang Z; Huang Y Int J Pharm; 2016 Mar; 500(1-2):100-9. PubMed ID: 26784985 [TBL] [Abstract][Full Text] [Related]
4. Time-staggered delivery of docetaxel and H1-S6A,F8A peptide for sequential dual-strike chemotherapy through tumor priming and nuclear targeting. Li L; Sun W; Zhang Z; Huang Y J Control Release; 2016 Jun; 232():62-74. PubMed ID: 27098443 [TBL] [Abstract][Full Text] [Related]
5. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells. Li J; Liu F; Shao Q; Min Y; Costa M; Yeow EK; Xing B Adv Healthc Mater; 2014 Aug; 3(8):1230-9. PubMed ID: 24550203 [TBL] [Abstract][Full Text] [Related]
6. Tumor targeting by pH-sensitive, biodegradable, cross-linked N-(2-hydroxypropyl) methacrylamide copolymer micelles. Zhou Z; Li L; Yang Y; Xu X; Huang Y Biomaterials; 2014 Aug; 35(24):6622-35. PubMed ID: 24814427 [TBL] [Abstract][Full Text] [Related]
7. Enhanced intracellular and intranuclear drug delivery mediated by biomimetic peptide SVS-1 for anticancer therapy. Xiang Y; Chen L; Zhou R; Huang Y Int J Pharm; 2019 Oct; 570():118668. PubMed ID: 31494237 [TBL] [Abstract][Full Text] [Related]
8. Subcellular co-delivery of two different site-oriented payloads for tumor therapy. Yang Q; Wu L; Li L; Zhou Z; Huang Y Nanoscale; 2017 Jan; 9(4):1547-1558. PubMed ID: 28067924 [TBL] [Abstract][Full Text] [Related]
9. Synergistic enhancement of anticancer therapeutic efficacy of HPMA copolymer doxorubicin conjugates via combination of ligand modification and stimuli-response srategies. Li L; Zhou M; Huang Y Int J Pharm; 2018 Jan; 536(1):450-458. PubMed ID: 29237570 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of primary and metastatic tumors in mice by E-selectin-targeted polymer-drug conjugates. Shamay Y; Raviv L; Golan M; Voronov E; Apte RN; David A J Control Release; 2015 Nov; 217():102-12. PubMed ID: 26297207 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of CD44v3 and CD44v6 function blocks tumor invasion and metastatic colonization. Zaiden M; Feinshtein V; David A J Control Release; 2017 Jul; 257():10-20. PubMed ID: 28093296 [TBL] [Abstract][Full Text] [Related]
12. Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl)methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkage. Nakamura H; Etrych T; Chytil P; Ohkubo M; Fang J; Ulbrich K; Maeda H J Control Release; 2014 Jan; 174():81-7. PubMed ID: 24269967 [TBL] [Abstract][Full Text] [Related]
13. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth. Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853 [TBL] [Abstract][Full Text] [Related]
14. Controlled apoptosis by a thermally toggled nanoscale amplifier of cellular uptake. MacEwan SR; Chilkoti A Nano Lett; 2014; 14(4):2058-64. PubMed ID: 24611762 [TBL] [Abstract][Full Text] [Related]
15. Selective intracellular delivery of proteasome inhibitors through pH-sensitive polymeric micelles directed to efficient antitumor therapy. Quader S; Cabral H; Mochida Y; Ishii T; Liu X; Toh K; Kinoh H; Miura Y; Nishiyama N; Kataoka K J Control Release; 2014 Aug; 188():67-77. PubMed ID: 24892974 [TBL] [Abstract][Full Text] [Related]
16. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery. Jiang T; Zhang Z; Zhang Y; Lv H; Zhou J; Li C; Hou L; Zhang Q Biomaterials; 2012 Dec; 33(36):9246-58. PubMed ID: 23031530 [TBL] [Abstract][Full Text] [Related]
17. HPMA copolymer-cyclic RGD conjugates for tumor targeting. Pike DB; Ghandehari H Adv Drug Deliv Rev; 2010 Feb; 62(2):167-83. PubMed ID: 19951733 [TBL] [Abstract][Full Text] [Related]
18. Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide. Lin C; Zhang X; Chen H; Bian Z; Zhang G; Riaz MK; Tyagi D; Lin G; Zhang Y; Wang J; Lu A; Yang Z Drug Deliv; 2018 Nov; 25(1):256-266. PubMed ID: 29334814 [TBL] [Abstract][Full Text] [Related]
19. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system. Zhang Q; Tang J; Fu L; Ran R; Liu Y; Yuan M; He Q Biomaterials; 2013 Oct; 34(32):7980-93. PubMed ID: 23891517 [TBL] [Abstract][Full Text] [Related]
20. Endogenous stimuli-sensitive multistage polymeric micelleplex anticancer drug delivery system for efficient tumor penetration and cellular internalization. Li J; Ke W; Li H; Zha Z; Han Y; Ge Z Adv Healthc Mater; 2015 Oct; 4(15):2206-19. PubMed ID: 26346421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]